Detalles de la búsqueda
1.
Safety and efficacy of baricitinib at 24â weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.
Ann Rheum Dis
; 74(2): 333-40, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25431052
2.
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study.
Ann Rheum Dis
; 74(8): 1567-70, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25873635
3.
Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis.
J Clin Densitom
; 18(4): 506-11, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25824332
4.
Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O).
J Clin Rheumatol
; 21(5): 231-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26203826
5.
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors.
Ann Rheum Dis
; 72(9): 1461-8, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23268367
6.
A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate.
Ann Rheum Dis
; 72(9): 1453-60, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23599435
7.
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
N Engl J Med
; 356(6): 567-79, 2007 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-17287477
8.
Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis.
J Rheumatol
; 43(2): 289-97, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26669919
9.
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study.
RMD Open
; 1(1): e000037, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26535134
10.
Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials.
Pediatr Pulmonol
; 37(5): 385-92, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15095320
11.
A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis.
Arthritis Res Ther
; 16(4): 415, 2014 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168268
12.
A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors.
Arthritis Rheumatol
; 66(7): 1693-704, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24623718
13.
The impact of diabetes and age on pulmonary function: data from the National Health and Nutrition Examination Survey.
Diabetes Res Clin Pract
; 83(1): e1-3, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19022514
14.
Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
Diabetes Technol Ther
; 11 Suppl 2: S35-44, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19772447
15.
Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
Diabetes Technol Ther
; 11 Suppl 2: S27-34, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19772446
16.
Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
Diabetes Technol Ther
; 11 Suppl 2: S5-S16, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19772449
17.
AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma.
Diabetes Care
; 31(4): 735-40, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18192544
18.
Rho GTPase Rac1 is critical for neutrophil migration into the lung.
Blood
; 109(3): 1257-64, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16990606
19.
Duration-dependent cytoprotective versus inflammatory effects of lung epithelial fibroblast growth factor-7 expression.
Exp Lung Res
; 33(8-9): 385-417, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17994369
20.
GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.
Am J Respir Cell Mol Biol
; 36(1): 114-21, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16917076